NCT05773495Active, not recruiting
Implementation of Teleophthalmology in Urban Health Systems Study
Source: ClinicalTrials.gov · Last updated 13 Feb 2026
Brief summary (registry, in English)
This study is being conducted to test the effectiveness of I-SITE (Implementation for Sustained Impact in Teleophthalmology), an implementation program to sustain increased diabetic eye screening rates using teleophthalmology in urban, multi-payer health systems.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 12840 (actual)
- First submitted
- 2 Mar 2023
- Start date
- 19 Mar 2024
- Primary completion date
- 1 Sept 2027
- Lead sponsor
- University of Wisconsin, Madison
- Diseases
- Diabetic eye disease
- NCT number
- NCT05773495
What you commit to
- Study type: Interventional
- Participants enrolled: 12840
- From 19 Mar 2024 to the primary completion date, 1 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Eligible medical records will be identified using ICD-10 codes for diabetes type 1 or type 2
- Billing data will be identified using teleophthalmology (CPT codes 92228 or 92250)
- Identification of eligible records will be performed by clinic personnel at each health system who already have full access to their patient data as part of their employment, and regularly gather and report this type of data to health insurers as part of their clinical role
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Wisconsin Coordinator of this site? Confirm its status | Madison | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.